Physician profile
Deepak Ravi
NPI 1548623796
$11,347.76
in general payments reported to CMS, 2019-2025
26 companies · $4,439 in 2025
The $4,439 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $75.23 · 2022: $581 · 2023: $2,709 · 2024: $3,544 · 2025: $4,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,752 · Travel and Lodging: $813 · Grant: $125 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,752.30 |
| Travel and Lodging | $813.40 |
| Grant | $125.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,258.90 | 2022-2025 | Optis, Coroflow, Pressurewire |
| Shockwave Medical, INC | $3,247.67 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abiomed | $1,452.40 | 2024-2025 | Impella |
| Medtronic, INC. | $903.48 | 2022-2025 | Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $428.94 | 2023-2025 | Avvigo Guidance System, Watchman Flx |
| Edwards Lifesciences Corporation | $340.81 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Cvrx, INC. | $336.90 | 2024-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $181.75 | 2025 | Camzyos |
| Pfizer INC. | $161.57 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $155.47 | 2020-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $146.13 | 2024-2025 | Winrevair, Verquvo |
| Biotronik INC. | $129.73 | 2022 | |
| Esperion Therapeutics, INC. | $124.72 | 2023 | Nexlizet, Nexletol |
| Penumbra, INC. | $123.55 | 2024 | Indigo System |
| Amgen INC. | $76.18 | 2025 | Repatha |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $42.99 | 2025 | Assure Wcd |
| Scpharmaceuticals INC. | $39.61 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $30.01 | 2025 | |
| Cathworks, INC. | $29.21 | 2024 | Ffrangio |
| Janssen Pharmaceuticals, INC | $26.52 | 2024 | Xarelto |
| Cardiovascular Systems INC. | $21.26 | 2022 | |
| Lantheus Medical Imaging, INC. | $21.01 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.71 | 2025 | Amvuttra |
| Cardiva Medical, INC. | $18.64 | 2024 | Cardiva Vascade 6/7f Vcs |
| Novo Nordisk INC | $17.61 | 2024 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $13.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Ravi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.